Trials / Active Not Recruiting
Active Not RecruitingNCT07266818
A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)
A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Effect of MK-1167 on QTc in Healthy Adult Participants
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The goal of this trial is to learn about the safety of MK-1167 and if people tolerate it.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK-1167 | Oral capsule administered once daily |
| DRUG | Placebo | Oral capsule administered once daily |
Timeline
- Start date
- 2025-12-18
- Primary completion
- 2026-04-13
- Completion
- 2026-04-13
- First posted
- 2025-12-05
- Last updated
- 2026-04-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07266818. Inclusion in this directory is not an endorsement.